Comparison of hybrid clones derived from human breast epithelial cells and three different cancer cell lines regarding in vitro cancer stem/ initiating cell properties

Fahlbusch, Sera Selina; Keil, Silvia; Epplen, Jörg T.; Zänker, Kurt S.; Dittmar, Thomas

doi:10.1186/s12885-020-06952-9

Table 1 Genotypic analysis of M13SV1-EGFP-Neo × MDA-MB-231-Hyg hybrid clones

From: Comparison of hybrid clones derived from human breast epithelial cells and three different cancer cell lines regarding in vitro cancer stem/ initiating cell properties

Locus	M13SV1- EGFP-Neo	MDA-MB- 231-Hyg	M13MDA 231–3	M13MDA 231–6	M13MDA 231–11	M13MDA 231–13
D3S138	120.00	128.16	120.00 128.24	119.87 128.17	120.00 128.16	119.87 128.16
TH01^a	157.84	165.72 176.59	157.84 165.81 176.62	157.71 165.75 176.69	157.83 165.80 176.61	157.85 165.77 176.63
D21S11	215.20	223.25 237.22	215.12 223.26 237.28	215.19 223.25 237.28	215.25 223.26 237.22	215.18 223.27 237.21
D18S51	298.85 333.02	295.08 314.01	295.00 298.84 314.00 332.94	295.10 298.86 314.03 333.05	295.11 298.84 313.94 332.98	294.93 298.73 313.87 332.91
Penta_E	408.02 413.04	408.07	407.99 413.10	407.92	408.03	408.11
D5S818	130.50 134.53	134.53	130.44 134.57	130.38 134.53	130.37 134.53	130.37 134.65
D13S317	179.65	195.66	179.77 195.71	179.76 195.69	179.65 195.66	179.77 195.71
D7S820	220.22 224.18	220.22 224.28	220.12 224.19	220.21 224.07	220.13 224.07	220.26 224.19
D16S539	290.77 302.78	290.76	290.81	290.77	290.69	290.78
CSF1PO^b	341.51 345.52	341.43 345.42	341.47 345.44	341.46 345.49	341.43 345.54	341.40 345.47
Penta_D	398.82 417.60	408.31 422.41	398.82 408.22 417.64 422.31	398.82 408.27 417.67 422.39	398.82 408.38 417.73 422.42	398.71 408.22 417.53 422.31
Amelo- genin	104.00	104.00	104.00	104.00	104.00	103.95
vWA^c	138.43 150.23	142.21 158.19	138.31 142.20 150.23 158.20	138.43 142.20 150.10 158.07	138.30 142.22 150.17 158.19	138.42 142.31 150.30 158.21
D8S1179	222.20 234.16	226.17	222.21 226.16 234.15	222.20 226.17 234.13	222.22 226.05 234.08	222.23 234.10
TPOX^d	280.87	268.86 272.91	268.98 272.91 280.81	268.89 272.81 280.84	268.98 273.03 280.81	268.98 272.92 280.88
FGA^e	341.39	345.54 349.65	341.47 345.56 349.77	341.46 345.49 349.65	341.44 345.61 349.77	341.40 345.58 349.77

^a TH01: human tyrosine hydrolase; ^b CSF1PO: human c-fms proto-oncogene for CSF-1 receptor; ^c vWA: human von Willebrand factor; ^d TPOX: human thyroid peroxidase; ^e FGA: human alpha fibrinogen

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Cancer

Contact us